{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"MaxCyte (MXCT) presentation at ShareSoc July 2018","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/30c2732c\"></iframe>","width":"100%","height":180,"duration":1802,"description":"Driving the next generation of cell-based medicinesBy Doug Doerfler – Founder, President & CEO\nIntroduction – 00:23Background and what MaxCyte does - 02:41Business model – 04:11CARMA platform, CAR therapy in oncology - 09:07Cell therapy programmes – business model – 16:12Revenue potential across multiple applications – 19:15Expected news flow - 21:36Summary & outlook – 22:182017 financial highlights - 22:50Q&A - 23:45","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}